Skip to main content
. 2020 Aug 8;15(4):549–565. doi: 10.1007/s11523-020-00736-8

Fig. 3.

Fig. 3

Cabozantinib dosing algorithm [7, 16]. AE adverse event, CYP3A4 cytochrome P450 3A4, GI gastrointestinal, ONJ osteonecrosis of the jaw